SCHEMBL81509

SCHEMBL81509

OCC#Cc1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1143333 0.83 FFAR1 (0.41)
SCHEMBL1142960 0.80 KDM4E (0.41)
SCHEMBL28477370 0.79 GRM5 (0.39)
SCHEMBL9906390 0.78
SCHEMBL7575126 0.78
SCHEMBL2491796 0.78 GRM5 (0.55)
Hydrochloric Acid SCHEMBL21803736 0.77 BLM (0.47)
SCHEMBL1143171 0.76 FFAR1 (0.36)
SCHEMBL8013270 0.76 DPP4 (0.51)
Charcoal, Activated SCHEMBL31286311 0.76 GRM5 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114057683-A Preparation method of tiotropium bromide intermediate 鲁南制药集团股份有限公司 2022-02-18 CN claimed
CN-115947668-A Preparation method of polysubstituted indene derivative 广东工业大学 2023-04-11 CN disclosed
CN-110483429-B Preparation method of 3, 5-disubstituted-4, 5-dihydroisoxazole 上海应用技术大学 2022-10-14 CN disclosed
CN-114057683-A Preparation method of tiotropium bromide intermediate 鲁南制药集团股份有限公司 2022-02-18 CN disclosed
CN-114057683-A Preparation method of tiotropium bromide intermediate 鲁南制药集团股份有限公司 2022-02-18 CN disclosed
US-9884832-B2 Inhibitors targeting drug-resistant influenza A THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2018-02-06 US disclosed
EP-2168944-B1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORP (JP) 2016-05-11 EP disclosed
US-20150191439-A1 INHIBITORS TARGETING DRUG-RESISTANT INFLUENZA A NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-07-09 US disclosed
WO-2014147009-A1 NOVEL MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2014-09-25 WO disclosed
WO-2014147009-A1 NOVEL MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2014-09-25 WO disclosed
US-20030144301-A1 Method of using 5-(arysulfonyl)-, 5-(arylsulfanyl)-and 5-(arylsulfanyl)thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase AMERICAN CYANAMID COMPANY (US) 2003-07-31 US disclosed
WO-2003018135-A1 METHOD OF USING 5-(ARYLSULFONYL)-,5-(ARYLSULFINYL), AND 5-(ARYLSULFANYL)-THIAZOLIDINE-2,4-DIONES FOR INHIBITION OF FARNESYL-PROTEIN TRANSFERASE WYETH HOLDINGS CORPORATION (US) 2003-03-06 WO disclosed
US-20020115697-A1 Heterocyclic compounds and their preparation and use JEPPESEN LONE (DK) 2002-08-22 US disclosed
EP-0900217-A4 HETEROCYCLIC COMPOUNDS LILLY CO ELI (US) 2001-05-23 EP disclosed
US-6069159-A USEFUL AS STIMULANTS OF THE COGNITIVE FUNCTION OF THE FOREBRAIN AND HIPPOCAMPUS OF MAMMALS ELI LILLY AND COMPANY (US) 2000-05-30 US disclosed
EP-0900217-A1 HETEROCYCLIC COMPOUNDS ELI LILLY AND COMPANY (US) 1999-03-10 EP disclosed
EP-0888355-A1 HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1999-01-07 EP disclosed
WO-1997040042-A1 HETEROCYCLIC COMPOUNDS ELI LILLY AND COMPANY (US) 1997-10-30 WO disclosed
WO-1997034899-A1 HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1997-09-25 WO disclosed
US-4322432-A Cyclopropanecarboxylic acid alkynyl esters, processes for producing them, and their use as pesticides CIBA-GEIGY CORPORATION (US) 1982-03-30 US disclosed